Trial Profile
The Effect of Antiangiogenic Therapy With Pazopanib Prior to Preoperative Chemotherapy for Subjects With Extremity Soft Tissue Sarcomas: A Randomized Study to Evaluate Response by Imaging
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Pazopanib (Primary) ; Doxorubicin; Ifosfamide
- Indications Soft tissue sarcoma
- Focus Pharmacokinetics; Therapeutic Use
- 06 Jun 2019 Status changed from active, no longer recruiting to completed.
- 05 Apr 2016 Status changed from recruiting to active, no longer recruiting, according to ClinicalTrials.gov record.
- 14 Dec 2015 Planned primary completion date changed from 1 Apr 2016 to 1 Oct 2016 as per ClinicalTrials.gov record.